Beverly Brown, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2314 E Buck Rd, Pennsburg, PA 18073 Phone: 215-300-2144 |
Ayesha Khan, MS, S-LP(C), SLP CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 530 Macoby St, Pennsburg, PA 18073 Phone: 215-679-8076 |
Lisa Brunner Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2314 E Buck Rd, Pennsburg, PA 18073 Phone: 215-300-2144 |
Karen Luma, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2314 E Buck Rd, Pennsburg, PA 18073 Phone: 215-300-2144 Fax: 267-923-5020 |
Hannah Marie Nicolas, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1009 Creekview Dr, Pennsburg, PA 18073 Phone: 267-566-6546 |
Cassidy Cox Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 530 Macoby St, Pennsburg, PA 18073 Phone: 215-679-8076 |
Lauren Yanan, M.A., CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1019 Lake Ln, Pennsburg, PA 18073 Phone: 215-896-8258 |
Mr. James Lemma Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 530 Macoby St, Pennsburg, PA 18073 Phone: 215-679-8076 |
News Archive
Although studies have shown that alcohol and cannabis misuse are related to impaired cognition in youth, previous studies were not designed to understand this relationship and differentiate whether cannabis use was causal or consequential to cognitive impairment.
Merck, a leading science and technology company is launching a range of new products for separation and analysis at the Pittcon Conference and Expo 2016 in Atlanta, Georgia, March 6 - 10, the world's largest conference for laboratory science.
People with symptoms suggesting rapid eye movement sleep behavior disorder, or RBD, have twice the risk of developing mild cognitive impairment (MCI) or Parkinson's disease within four years of diagnosis with the sleep problem, compared with people without the disorder, a Mayo Clinic study has found.
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that breast cancer cells that metastasize to the lung express a higher level of the protein peroxiredoxin 2 (PRDX2). The study suggests that the modulation of the levels of this protein could be a new therapeutic strategy to prevent lung metastases.
› Verified 2 days ago